Canada Life
IDYA icon

Canada Life’s IDEAYA Biosciences IDYA Stock Holding History

Canada Life’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Buy
8,232
+596
+8% +$18.2K ﹤0.01% 1547
2026
Q1 		$255K Hold
7,636
– – ﹤0.01% 1572
2025
Q4 		$264K Sell
7,636
-9,780
-56% -$312K ﹤0.01% 1595
2025
Q3 		$474K Hold
17,416
– – ﹤0.01% 1611
2025
Q2 		$367K Buy
17,416
+1,609
+10% +$30.9K ﹤0.01% 1652
2025
Q1 		$259K Hold
15,807
– – ﹤0.01% 1702
2024
Q4 		$406K Hold
15,807
– – ﹤0.01% 1673
2024
Q3 		$501K Hold
15,807
– – ﹤0.01% 1669
2024
Q2 		$555K Buy
15,807
+4,708
+42% +$186K ﹤0.01% 1662
2024
Q1 		$487K Buy
11,099
+6,069
+121% +$261K ﹤0.01% 1694
2023
Q4 		$178K Hold
5,030
– – ﹤0.01% 1857
2023
Q3 		$136K Buy
5,030
+2,973
+145% +$75.4K ﹤0.01% 1914
2023
Q2 		$49K Hold
2,057
– – ﹤0.01% 2009
2023
Q1 		$28K Hold
2,057
– – ﹤0.01% 2156
2022
Q4 		$38K Buy
2,057
+1,036
+101% +$17.4K ﹤0.01% 2134
2022
Q3 		$15K Hold
1,021
– – ﹤0.01% 2299
2022
Q2 		$14K Hold
1,021
– – ﹤0.01% 2325
2022
Q1 		$12K Hold
1,021
– – ﹤0.01% 2413
2021
Q4 		$24K Buy
+1,021
New +$23.7K ﹤0.01% 2340

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Canada Life's IDYA Position: Q2 2026 in Review

Canada Life increased its IDEAYA Biosciences (IDYA) stake by 7.8% in Q2 2026, buying an estimated $18.2K and bringing the position to 8,232 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Canada Life first reported a position in IDYA in Q4 2021 and has held it in 19 quarters since. The position peaked at $555K in Q2 2024. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Canada Life held 8,232 shares of IDEAYA Biosciences worth $306K as of Q2 2026.
  • Canada Life bought 596 IDEAYA Biosciences shares in Q2 2026, an estimated $18.2K.
  • IDEAYA Biosciences made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1547 holding.
  • Canada Life first reported a position in IDEAYA Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Canada Life's IDEAYA Biosciences position peaked at $555K in Q2 2024.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.